Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
Status: | Completed |
---|---|
Conditions: | Lymphoma |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 35 - Any |
Updated: | 3/10/2017 |
Start Date: | June 2007 |
End Date: | January 2017 |
Procurement of Follicular B Cell Lymphoma Cells From Blood, Tissue or Malignant Effusion for the Purpose of Possible Use in Future Clinical Trials: A Minimal Risk Protocol
In order to learn more about follicular lymphoma and anti-cancer vaccines, we are collecting
samples from people with this diagnosis. We then hope to make a vaccine from this tissue to
help the immune system destroy cancer cells. We plan on keeping samples in the tissue bank
indefinitely.
samples from people with this diagnosis. We then hope to make a vaccine from this tissue to
help the immune system destroy cancer cells. We plan on keeping samples in the tissue bank
indefinitely.
- The following tests and procedures will be performed: Approximately 50cc of peripheral
blood will be drawn and stored in the tissue bank; patients who have follicular lymphoma
cells circulating in the blood will have about 40cc's of blood drawn and stored for
processing; patients undergoing a lymph node biopsy will have samples of the biopsy stored;
patients having fluid drained from the abdomen or from around the lung will have some of
their fluid saved to cell collection and processing; patients undergoing a bone marrow
biopsy will have some of the sample stored for cell collection and processing.
blood will be drawn and stored in the tissue bank; patients who have follicular lymphoma
cells circulating in the blood will have about 40cc's of blood drawn and stored for
processing; patients undergoing a lymph node biopsy will have samples of the biopsy stored;
patients having fluid drained from the abdomen or from around the lung will have some of
their fluid saved to cell collection and processing; patients undergoing a bone marrow
biopsy will have some of the sample stored for cell collection and processing.
Inclusion Criteria:
- Relapsed, refractory or de novo histologically confirmed follicular B-cell lymphoma
with accessible lymph nodes, tumor mass or malignant effusion or peripheral blood
- 35 years of age or older
Exclusion Criteria:
- Uncontrolled active infection
- HIV or viral Hepatitis infection
- Other current malignancies except any in situ cancer or basal or squamous cell
carcinoma of the skin
- Autoimmune cytopenias
We found this trial at
1
site
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
Click here to add this to my saved trials